[Note that many of these links expire after a few weeks]
Saved Google Search 02/02/2003 . . . courtesy of
[Note that many of these links expire after a few weeks]
|
Preferences Search Tips | ||||||
|
|
|
|
|
|
 |
|
|
| |||||||||||||||||||||||||||||||||||||
| Sort by relevance Sorted by date |
Did you mean: Strata
Strong
quarter caps '02 for Lilly
Indianapolis
Star, IN - 23 Jan 2003
...
Two drugs hit the US market in the past few weeks: Strattera for
attention-deficit
hyperactivity disorder and Forteo for osteoporosis.
...
Lilly
Posts Profit, but Issues Warning
ABC
News - 23 Jan 2003
... It won
approval in November for two long-delayed medicines, Strattera
for
attention deficit disorder and Forteo for osteoporosis. ...
Lilly
Posts Profit, but Issues Warning
Reuters, UK - 23 Jan 2003
... It won approval in November for two long-delayed medicines,
Strattera
for attention deficit disorder and Forteo for osteoporosis.
...
Lilly
Posts 28 Percent Earnings Increase
Austin
American Statesman, TX - 23 Jan 2003
... president and chief executive, said the drug maker has turned
the corner with the
November approval of two drugs: Forteo, to treat
osteoporosis, and Strattera ...
Lilly
Posts 28 Percent Earnings Increase
ABC
News - 23 Jan 2003
... president
and chief executive, said the drug maker has turned the corner with
the
November approval of two drugs: Forteo, to treat osteoporosis, and
Strattera ...
Lilly
Posts 28 Percent Earnings Increase
Kansas
City Star, MO - 23 Jan 2003
... president and chief executive, said the drug maker has turned
the corner with the
November approval of two drugs: Forteo, to treat
osteoporosis, and Strattera ...
Lilly
Earnings Rise, but Shares Fall
ABC
News - 23 Jan 2003
... president
and chief executive, said the drug maker has turned the corner with
the
November approval of two drugs: Forteo, to treat osteoporosis, and
Strattera ...
3
Drugmakers Post Gains, 2003 Seen Hard
ABC
News - 23 Jan 2003
... He said
Lilly should emerge strong after 2003 because of the recent approval of
its
drug Strattera for attention deficit disorder and expected approval this
...
Lilly's And
Schering's Blockbuster Hangovers
Forbes - 23 Jan 2003
... Strattera, a nonstimulant treatment for attention
deficit disorder, and osteoporosis
drug Forteo have both been approved by the
FDA and launched in the past ...
Lilly's And
Schering's Blockbuster Hangovers
Forbes - 23 Jan 2003
... Strattera, a nonstimulant treatment for attention
deficit disorder, and osteoporosis
drug Forteo have both been approved by the
FDA and launched in the past ...
3
Drugmakers Post Gains, 2003 Seen Hard
Reuters, UK - 23 Jan 2003
... He said Lilly should emerge strong after 2003 because of the
recent approval of
its drug Strattera for attention deficit disorder
and expected approval this ...
Lilly
Posts 28 Percent Earnings Increase
Austin
American Statesman, TX - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat
osteoporosis,
and Strattera, for attention deficit/hyperactivity
disorder. ...
Lilly
Posts 28 Percent Earnings Increase
Springfield News Sun, OH - 23 Jan
2003
... 29 regulatory approval of two drugs:
Forteo, to treat osteoporosis,
and Strattera, for attention
deficit/hyperactivity disorder. ...
Lilly
Posts 28 Percent Earnings Increase
Seattle Times, WA - 23 Jan
2003
... 29 regulatory approval of two drugs:
Forteo, to treat osteoporosis,
and Strattera, for attention
deficit/hyperactivity disorder. ...
Lilly Posts
28 Percent Earnings Increase
ABC
News - 23 Jan 2003
... 29
regulatory approval of two drugs: Forteo, to treat osteoporosis,
and
Strattera, for attention deficit/hyperactivity disorder. ...
Lilly Posts
28 Percent Earnings Increase
ABC
News - 23 Jan 2003
... 29
regulatory approval of two drugs: Forteo, to treat osteoporosis,
and
Strattera, for attention deficit/hyperactivity disorder. ...
Lilly
Posts 28 Percent Earnings Increase
San
Jose Mercury News, CA - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat
osteoporosis,
and Strattera, for attention deficit/hyperactivity
disorder. ...
Lilly
Posts 28 Percent Earnings Increase
Miami
Herald, FL - 23 Jan 2003
... 29 regulatory approval of two drugs: Forteo, to treat
osteoporosis,
and Strattera, for attention deficit/hyperactivity
disorder. ...
Lilly Posts
28 Percent Earnings Increase
ABC
News - 23 Jan 2003
... 29
regulatory approval of two drugs: Forteo, to treat osteoporosis,
and
Strattera, for attention deficit/hyperactivity disorder. ...
Lilly
Posts 28 Percent Earnings Increase
Sarasota Herald-Tribune, FL - 23 Jan
2003
... 29 regulatory approval of two drugs:
Forteo, to treat osteoporosis,
and Strattera, for attention
deficit/hyperactivity disorder. ...
Lilly
Posts 28 Percent Earnings Increase
Springfield News Sun, OH - 23 Jan
2003
... 29 regulatory approval of two drugs:
Forteo, to treat osteoporosis,
and Strattera, for attention
deficit/hyperactivity disorder. ...
Lilly
Posts 28 Percent Earnings Increase
Lakeland Ledger, FL - 23 Jan
2003
... 29 regulatory approval of two drugs:
Forteo, to treat osteoporosis,
and Strattera, for attention
deficit/hyperactivity disorder. ...
Lilly
Posts 28 Percent Earnings Increase
Seattle Post Intelligencer, WA - 23 Jan
2003
... 29 regulatory approval of two drugs:
Forteo, to treat osteoporosis,
and Strattera, for attention
deficit/hyperactivity disorder. ...
Lilly's
Fourth Quarter Marks a Return to Quarterly Sales Growth ...
BusinessWire (press release) - 23 Jan
2003
... Strattera(TM) was approved by the
US Food and Drug Administration (FDA) for the
treatment of attention-deficit
hyperactivity disorder (ADHD) in children ...
5 For
Kids: New ADHD Drug
WLWT, OH - 20 Jan 2003
... But now, there is a new drug on the market known as
Strattera. It's the first FDA
approved non-stimulant that
manufacturers say will offer fewer side-effects. ...
Drugmakers
Rx: can't get much worse
CNN
Europe, Europe - 20 Jan 2003
... As for Eli Lilly, in November it won federal marketing
approval for
Strattera, to treat attention deficit hyperactivity
disorder. ...
Drugmakers
Rx: can't get much worse
CNN/Money - 20 Jan 2003
... As for Eli Lilly, in November it won federal marketing
approval for
Strattera, to treat attention deficit hyperactivity
disorder. ...
Eli
Lilly: Straterra likely to narrow revenue deficit
UK Comment Wire, UK - 17 Jan
2003
January 17, 2003 12:50 PM GMT (Datamonitor) - Eli
Lilly's Strattera
is set to add a new dimension to the US ADHD market.
It is the ...
Lilly's
ADHD drug hits the market
Indianapolis
Star, IN - 15 Jan 2003
...
Strattera is expected to be a major seller for the Indianapolis drugmaker
as a
treatment for attention-deficit/hyperactivity disorder in both children
and ...
Daily
briefing
The News
Journal, DE - 15 Jan 2003
... Eli Lilly and Co., which won federal marketing approval for
Strattera
in November, said more than 46000 pharmacies have stocked
the drug.
New Lilly drug
expects promising sales
WTHR, IN - 14 Jan 2003
Cathie's son took part in a clinical trial on the Eli Lilly and
Company
drug Strattera. It hit pharmacy shelves Tuesday.
Strattera ...
Lilly's
Attention Deficit Drug Available
WMAR
(ABC2), MD - 14 Jan 2003
Lilly,
which won federal marketing approval for Strattera in November, said
more
than 46000 pharmacies have stocked the drug and can begin filling
prescriptions ...
New
attention deficit drug hits US pharmacies
CTV, Canada - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in
November, said more
than 46000 pharmacies have stocked the drug and can begin
filling prescriptions ...
Lilly's
new attention deficit drug Strattera hits US pharmacies
Ottawa Citizen, Canada - 14 Jan
2003
Lilly, which won federal marketing approval for
Strattera in November, said more
than 46000 pharmacies have stocked
the drug and can begin filling prescriptions ...
Lilly's
new attention deficit drug Strattera hits US pharmacies
St. Catharines
Standard, Canada - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in
November, said more
than 46000 pharmacies have stocked the drug and can begin
filling prescriptions ...
Lilly's
new attention deficit drug Strattera hits US pharmacies
Canada.com, Canada - 14 Jan
2003
Lilly, which won federal marketing approval for
Strattera in November, said more
than 46000 pharmacies have stocked
the drug and can begin filling prescriptions ...
New
Lilly drug arrives in pharmacies
Indianapolis Star, IN - 14 Jan
2003
... Strattera is expected to be a
major seller for the Indianapolis drugmaker as a
treatment for
attention-deficit/hyperactivity disorder in both children and ...
Lilly's
Attention Deficit Drug Available
Sarasota
Herald-Tribune, FL - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in
November, said more
than 46000 pharmacies have stocked the drug and can begin
filling prescriptions ...
Lilly's
Attention Deficit Drug Available
ABC
News - 14 Jan 2003
Lilly, which won
federal marketing approval for Strattera in November, said more
than
46000 pharmacies have stocked the drug and can begin filling prescriptions
...
Lilly's
Attention Deficit Drug Available
Lakeland
Ledger, FL - 14 Jan 2003
Lilly,
which won federal marketing approval for Strattera in November, said
more
than 46000 pharmacies have stocked the drug and can begin filling
prescriptions ...
Lilly's
Attention Deficit Drug Available
Times
Daily, AL - 14 Jan 2003
Lilly,
which won federal marketing approval for Strattera in November, said
more
than 46000 pharmacies have stocked the drug and can begin filling
prescriptions ...
Lilly's
Attention Deficit Drug Available
Newsday - 14 Jan 2003
... Lilly, which won federal marketing approval for
Strattera in November, said more
than 46000 pharmacies have stocked
the drug and can begin filling prescriptions ...
Lilly's
New ADHD Drug Now Available in Pharmacies
WISH, IN - 14 Jan 2003
... in pharmacies. The drug is called Strattera and is the
first non-stimulant
drug approved by the FDA for treating ADHD. Lilly says
...
Lilly's
new attention deficit drug hits pharmacies
Miami Herald, FL - 14 Jan 2003
Lilly, which won federal marketing approval for Strattera in
November, said more
than 46000 pharmacies have stocked the drug and can begin
filling prescriptions ...
Shire
Pharma shares hit by threat to lead drug
Independent, UK - 09 Jan 2003
... Eli Lilly, the US pharmaceutical giant, has recently launched
Strattera,
a new kind of drug for hyperactive children and adults.
...
Drugs:
Relief from the Pain
BusinessWeek - 06 Jan 2003
... Eli Lilly & Co. (LLY ) is also likely to launch
Strattera, for attention-deficit
hyperactivity disorder, and a new
antidepressant called Cymbalta. ...
Did you mean to search for: Strata
|
| Google Home - Advertise with Us - Search Solutions - Services & Tools - Jobs, Press, & Help |
